News

CMS: Medicare to Cover On-Label Use of Provenge

Publish date: March 31, 2011

 

This coverage is provided courtesy of “The Pink Sheet.” “The Pink Sheet” and Internal Medicine News Digital Network are both owned by Elsevier.

Pages

Recommended Reading

NCCN Breast Guidelines Stand by Bevacizumab
MDedge Internal Medicine
FDA Panel Supports Device That Targets Brain Tumors
MDedge Internal Medicine
More NCI Cooperative Groups Forming Alliances
MDedge Internal Medicine
Thin Endometrial Echo Complex Does Not Rule Out Cancer
MDedge Internal Medicine
NCCN Upgrades Rituximab Regimens for Follicular Lymphoma
MDedge Internal Medicine
Ipilimumab Approval Was Desperately Needed
MDedge Internal Medicine
FDA: Ipilimumab Approved for Metastatic Melanoma
MDedge Internal Medicine
NCI’s Cancer Research Gambit
MDedge Internal Medicine
Radiation From Backscatter X-Ray Scans Poses Little Cancer Risk
MDedge Internal Medicine
Study Finds Few Second Cancers Attributable to Radiotherapy
MDedge Internal Medicine